'TRULY DREADFUL WAVE'A spokesman for Serum Institute of India, the world's biggest vaccine maker, said the focus for now is on supplying vaccines to India.
It had previously expected shipments to restart from June.Asked about the October timeline, COVAX co-lead GAVI told Reuters at least 140 million doses it had expected from the Serum Institute by the end of May will now remain in India."As India confronts a truly dreadful wave of the pandemic, Indian vaccine production, including the 140 million vaccine doses initially destined for COVAX, have been committed to protecting its own citizens," a GAVI spokeswoman said in an email."We offer the government of India our full support in their effort to bring the virus under control and stand.